Skip to content
Search

Latest Stories

DHSC’s proposed 2.8% pay uplift is ‘an insult’ to dedicated NHS staff – says Unite the Union

DHSC has proposed a 2.8% pay uplift for NHS Agenda for Change (AfC) staff
Closeup of pharmacist's hands taking medicines from shelf at the pharmacy

The Guild of Healthcare Pharmacists also argues that the recommended pay uplift fails to account for rising costs such as mortgages, rent, utilities and food bills

The Department of Health and Social Care (DHSC) has proposed a 2.8% pay uplift for NHS Agenda for Change (AfC) staff, including hospital pharmacists, for the 2025/2026 pay round.

This recommendation was detailed in the DHSC’s submission to the NHS Pay Review Body (NHSPRB), which described the figure as “a reasonable amount to have set aside based on the macroeconomic data and forecasts and taking into account the fiscal and labour market context.”


NHS England also supported the 2.8% pay increase, stating that its proposal reflects “the likely NHS budget from discussions to date with DHSC and what was set out by HM Treasury in the Autumn Budget 2024.”

“We propose to set allocations for NHS planning on the basis of a 2.8% pay settlement. Every 0.5% increase above that costs around £700m; which is the equivalent to around 2% of elective activity (greater than 300k completed patient pathways),” it added.

However, Unite the Union, representing NHS staff, condemned the DHSC’s recommendation, called the proposed increase “an insult.”

Unite general secretary Sharon Graham said: “The NHS recruitment and retention crisis will not be solved without taking the issue of restorative pay seriously. The NHS still desperately needs to attract more workers after 14 years of below-inflation pay increases.”

“This latest below-inflation pay recommendation is an insult to dedicated NHS staff and further evidence that the [NHS] Pay Review Body is broken beyond repair.”

“Unite has long been saying that NHS pay concerns must be resolved through direct negotiations with government,” she added.

Unite also raised concerns that, if accepted, the proposal would leave over 200,000 NHS workers in grade two earning below the real living wage of £12.60 per hour for 2025.

Rob Connah, president of the Guild of Healthcare Pharmacists (GHP), pointed out that the 2.8% pay uplift does not address restorative pay for staff on Agenda for Change.

“Real-terms pay has been decimated for over ten years,” he said, stressing that any pay recommendation should take into account increasing costs, such as mortgages, rent, utilities and food bills in addition to inflation.

In July 2024, NHS staff received a 5.5% pay increase for 2024/2025, following the NHSPRB's recommendation.

Unite announced in September 2024 that two-thirds of its members had voted to approve the offer.

For the 2024 to 2025 pay round, the NHSPRB made three recommendations, including a headline pay uplift, a change to the progression within bands 8 and 9, and a funded mandate to the NHS Staff Council to address structural issues in the Agenda for Change contract.

The government accepted all three recommendations and has implemented the first two.

The DHSC reiterated its commitment to addressing the AfC pay structure issues.

“Government is currently operating within an extremely challenging fiscal position, and funding for the AfC pay structure has needed to be carefully considered alongside all other spending priorities.”

“To enable us to provide this funding in the 2025 to 2026 pay year, we intend to use a proportion of the overall funding that we have set aside to invest in AfC pay,” it stated.

Final pay recommendations for the 2025/2026 period will be announced after April 1, 2025.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less